| 1 |
Furukawa T,Yoshimura A,Sumizawa T,et al.Angiogenic factor.Nature,1992,356(6371): 668.
|
| 2 |
Sumizawa T,Furukawa T,Haraguchim M,et al.Thymidine phosphorylase activity with platelet-derived endothelial cell growth factor. J Biochem,1993,114(1):9-14.
|
| 3 |
Miyadera K, Dohmae N, Takio K, et al. Structural of characterization thymidine phosphorylase purled from human placenta.Biochem Biophys Res Commun,1995,212(3):1040-1045.
|
| 4 |
肖永胜,周俭,汤钊猷,等.干扰素诱导人肝细胞癌胸苷磷酸化酶表达和拮抗血管生成的实验研究.中华医学杂志,2005,85(45):3205-3209.
|
| 5 |
肖永胜,汤钊猷,樊嘉,等.转染胸苷磷酸化酶基因对肝癌细胞的双重影响.中华实验外科杂志,2004,21(9):1053-1055.
|
| 6 |
Focher F,Ubiali D,Pregnolato M,et al.Novel nonsubstrate inhibitors of human thymidine phosphorylase，a potential target for tumor-dependent angiogenesis.J Med Chem,2000,43(3):2601-2607.
|
| 7 |
Yoshimura a，Kuwauru Y,Furukawa T,et al.Purification and tissue distribution of human thymidine phosphorylase；high expression in lymphoeytes and tumors.Biachem Biophy Acta,1990,1034(1):107-113.
|
| 8 |
Folkman J.What is the evidence that tumors are angiogenesis dependent?J Natl Cancer Inst,1990,82(1):4-6.
|
| 9 |
宋修峰,王滨,高志芹,等.胸苷磷酸化酶在肝细胞癌中的表达及临床意义.天津医科大学学报,2006,12(2):229-231.
|
| 10 |
Takebayashi Y, Miyadera K, Akiyama S, et al. Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res,1996,87(3):288-295.
|
| 11 |
Miyadera K,Sumizawa T,Haraguehi M,et al.Role of thymidine phos phorylase activity in the angiogenic effect of plateletderived endothelial cell growth factor/thymidine phosphorylase. Cancer Research,1995,55(8):1687-1690.
|
| 12 |
Stevenson DP,Milligan SR,Collins WP,et al.Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase,substrate,and products in a three-dimensional model of angiogenesis. Am J Pathol,1998,152(6):1641-1646.
|
| 13 |
Brown NS, Jones A, Fujiyama C, et al. Thymidine phosphorylase induce carcinoma cell oxidative stress and promotes secretion of angiogenic factors.Cancer Research,2000,60(22):6298-6302.
|
| 14 |
Moghaddam A,Zhang HT, Fan TP, t a1. Thymidine phosphorylase is angiogenic and promotes tumor growth.Proe Natl Acad Sci USA,1995,99(4):998-1002.
|
| 15 |
Takebayashi Y, Akiyama S, Akiba S, et al. Clinicopathologic and prognostic significance of an angiogenic factor,thymidine phosphorylase,in human colorectal carcinoma.J Natl Cancer last,1996,88(16):1110-1117.
|
| 16 |
Koide N, Watanabe H, Yazawa K, et al. Immunohistochemical expression of thymidine phosphorylase／platelet-derived endothelial cell growth factor in squamous cell carcinoma of the esophagus.Hepato Gastroenterology,1999,46(26):944-951.
|
| 17 |
Kikuyama S,Inada T,Shimizu K,et al.Thymidine phosphorylase expression in gastric cancer in association with proliferative activity and an～ogenesis.Anticancer Res,2000,20(3B):2081-2086.
|
| 18 |
Konno S, Takebayashi Y, Aibac M, et al. Clinicopathological and prognostic significance of thymidine phosphorylase and proliferating cell nuclear antigen in gastric carcinoma. Cancer Lett, 2001, 166(1):103-111.
|
| 19 |
Kitazono M,Takebayashi Y,Ishitsuka K,et al. Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase.Biochem Biophy Res commun.1998,253(3):797-803.
|
| 20 |
Ikeda R,Furukawa T,Kitazono M,et al.Molecular basis for the inhibition of hypoxia-induced apoptosis by 2-deoxy-diribose. Biochem Bioph Res commun,2002,291(4):806-812.
|
| 21 |
Maeda K, Chung Y-S, Ogawa S, et al. Thymidine phosphorylase/plateletderived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma.Br J Cancer,1996,73(8):884-888.
|
| 22 |
Ueda M, Terai Y, Kumagai K, et al. Correlation between thymidine phosphorylase expression and invasion phenotype in cervical carcinoma cells.Int J Cancer，2001,91(6):778-782.
|
| 23 |
Ezaki T, Ikegami T, Maeda T, et al. Prognostic value of thymidine phosphorylase activity in liver tissue adjacent to hepatocellular carcinoma.Int J Oncol(2005)10:171-176.
|
| 24 |
Patterson AV,Zhang H, Moghaddam A, et al. Increased sensitivity to the predrug 5'-deoxy-5-fluorouridine and modulation of 5-fluoro-2' deoxyuridine sensitivity in MCF-7721 cells transfected with thymldine phosphorylase.Br J Cancer,72(3):669-675.
|
| 25 |
Cassidy J, Dirix L, Bissett D, et al. A phase I study of capecitabin in combination with oral leucovorin in patients with intractable solid tumors.Clin Cancer Res,1998,4(11):2755-2761.
|
| 26 |
Ishikawa T, Utoh M, Sawads N, et al. Tumor selective delivery of 5-fluorouracil by capecitabine，a new oral fluoropyrimidine carbamate, in human cancer xenografts. Biochem Pharmaeol, 1998, 55(7):1091-1097.
|
| 27 |
Mori K,Hasegawa M,Nishida M,et al.Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues.Int Oncol,2000,17(1):33-38.
|